Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.
Clin Microbiol Rev
; 29(1): 163-74, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26607813
ABSTRACT
Rubella virus usually causes a mild infection in humans but can cause congenital rubella syndrome (CRS). Vaccination programs have significantly decreased primary rubella virus infection and CRS; however, vaccinated individuals usually have lower levels of rubella virus IgG than those with natural infections. Rubella virus IgG is quantified with enzyme immunoassays that have been calibrated against the World Health Organization (WHO) international standard and report results in international units per milliliter. It is recognized that the results reported by these assays are not standardized. This investigation into the reasons for the lack of standardization found that the current WHO international standard (RUB-1-94) fails by three key metrological principles. The standard is not a pure analyte but is composed of pooled human immunoglobulin. It was not calibrated by certified reference methods; rather, superseded tests were used. Finally, no measurement uncertainty estimations have been provided. There is an analytical and clinical consequence to the lack of standardization of rubella virus IgG assays, which leads to misinterpretation of results. The current approach to standardization of rubella virus IgG assays has not achieved the desired results. A new approach is required.
Full text:
1
Database:
MEDLINE
Main subject:
Rubella virus
/
Immunoglobulin G
/
Enzyme-Linked Immunosorbent Assay
/
Antibodies, Viral
Limits:
Humans
Language:
En
Year:
2016
Type:
Article